From 2030, all new harbour craft in Singapore must be fully electric or capable of running on B100 biofuel or other net-zero ...
MOL PLUS decides to invest in Pyxis Maritime for small EV vessels and charging business. Find the latest news from the maritime industry on the PortNews website.
Equity-Insider.com News Commentary – The biotechnology sector is entering a high-stakes survival sprint as major pharmaceutical giants confront a looming $170 ...
Blackmagic ’s Pyxis 12K arrives as one of the most compelling cinema cameras of the moment, packing a full-frame 12K RGBW ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
Jesse Calis spent a month with the Blackmagic PYXIS 12K cinema camera. His verdict: “If you are a serious filmmaker… this camera is really for you.” And how. Watch his full review of the Blackmagic ...
Shares of Pyxis Oncology dropped after the pharmaceutical company said data from its trials on a treatment for a form of head and neck cancer showed a high incidence of adverse effects. The stock fell ...
Investing.com -- Pyxis Oncology Inc (NASDAQ:PYXS) stock tumbled 49.9% in premarket trading Thursday after investors expressed disappointment with preliminary data from the company’s experimental ...
BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...
46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in ...
If you've seen images of the iconic "Home Alone" house when it was put up for sale in suburban Winnetka, you may have noticed the home appeared quite different from its nostalgic look in the holiday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results